| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.069 | 0.02 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |